Extending Business Aviation Safety Standards to Urban Air Mobility;Signed Deals with…
July 23, 2026
AH-008 Achieves Key Clinical Milestone with Successful First Subject First Dose (FSFD) in Phase I Study for Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
TAIPEI, July 23, 2026 /PRNewswire/ — AnHorn Medicines today announced the successful…